Growth Metrics

Quest Diagnostics (DGX) Return on Equity (2017 - 2025)

Historic Return on Equity for Quest Diagnostics (DGX) over the last 16 years, with Q3 2025 value amounting to 0.14%.

  • Quest Diagnostics' Return on Equity rose 100.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.14% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Quest Diagnostics' Return on Equity stood at 0.14%, which was up 100.0% from 0.14% recorded in Q2 2025.
  • Quest Diagnostics' 5-year Return on Equity high stood at 0.31% for Q4 2021, and its period low was 0.07% during Q1 2021.
  • Over the past 5 years, Quest Diagnostics' median Return on Equity value was 0.14% (recorded in 2024), while the average stood at 0.17%.
  • Examining YoY changes over the last 5 years, Quest Diagnostics' Return on Equity showed a top increase of 2200bps in 2022 and a maximum decrease of -1500bps in 2022.
  • Over the past 5 years, Quest Diagnostics' Return on Equity (Quarter) stood at 0.31% in 2021, then plummeted by -49bps to 0.16% in 2022, then dropped by -13bps to 0.14% in 2023, then decreased by -4bps to 0.13% in 2024, then grew by 3bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q3 2025, 0.14% for Q2 2025, and 0.13% during Q1 2025.